SESN Company Profile and Key Details
Sesen Bio, Inc.
SESN Stock Price Chart
Stock Price Today
Sesen Bio, Inc. (SESN) stock surged +7.29%, trading at $0.63 on NASDAQ, up from the previous close of $0.59. The stock opened at $0.57, fluctuating between $0.57 and $0.63 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Company Information
| Employees | 17 |
| Beta | 0.83 |
| Sales or Revenue | $40.00M |
| 5Y Sales Change% | 244% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Sesen Bio, Inc. (NASDAQ: SESN) stock price is $0.63 in the last trading session. During the trading session, SESN stock reached the peak price of $0.63 while $0.57 was the lowest point it dropped to. The percentage change in SESN stock occurred in the recent session was 7.29% while the dollar amount for the price change in SESN stock was $0.04.
The NASDAQ listed SESN is part of Biotechnology industry that operates in the broader Healthcare sector. Sesen Bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Mark R. Sullivan
Gen. Counsel & Corporation Sec.
Dr. Thomas R. Cannell D.V.M.
Pres, Chief Executive Officer & Director
Dr. Glen C. MacDonald
Chief Technology Officer
Dr. David Brooks
Senior Vice President of Clinical Devel.
Mr. John Knighton
Vice President & Chief Compliance Officer
Mr. Steve Barbera
Vice President of Market Access
Ms. Erin Clark
Vice President of Corporation Strategy & Investor Relations
Ms. Monica Forbes
Chief Financial Officer & Treasurer
Dr. Gregory L. Verdine Ph.D.
Co-Founder
Dr. Dennis Kim M.D., MPH
Chief Medical Officer
SESN's closing price is 72.27% higher than its 52-week low of $0.37 where as its distance from 52-week high of $0.97 is -34.84%.
Number of SESN employees currently stands at 17.
Official Website of SESN is: https://sesenbio.com
SESN could be contacted at phone 617 444 8550 and can also be accessed through its website. SESN operates from 245 First Street, Cambridge, MA 02142, United States.
SESN stock volume for the day was 1.78M shares. The average number of SESN shares traded daily for last 3 months was 1.24M.
The market value of SESN currently stands at $127.96M with its latest stock price at $0.63 and 203.49M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com